Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Provident Pharmaceuticals LLC
WARNING LETTER
•Provident Pharmaceuticals LLC•June 19, 2009

Provident Pharmaceuticals LLC – FDA Warning Letter, Jun 19, 2009

Record Details

An FDA inspection of Provident Pharmaceuticals, LLC, from June 1-19, 2009, revealed significant Current Good Manufacturing Practice (CGMP) violations (21 CFR 210 and 211), rendering drug products adulterated under 21 U.S.C. § 351(a)(2)(B). The firm also manufactures unapproved new prescription drugs, violating 21 U.S.C. §§ 331(d) and 355(a), and these drugs are misbranded per 21 U.S.C. § 352(f)(1), violating 21 U.S.C. § 331(a).

Key CGMP violations include the Quality Control Unit's (QCU) failure to: establish valid test methods, ensure stability samples are tested on schedule, conduct annual product reviews, thoroughly investigate Out-of-Specification (OOS) results, and perform internal audits of corrective actions. Test methods for components and drug products were not validated, violating 21 CFR 211.165(e). The firm failed to conduct annual product reviews (21 CFR 211.180(e)) and thoroughly investigate OOS results (21 CFR 211.192), including invalidating confirmed OOS results without justification. The stability testing program was not followed,

Company
Provident Pharmaceuticals LLC
Inspection date
June 19, 2009
Product type
Drugs
Office
Denver District Office
Person
  • Thomas Warwick (H.)
View Company Profile

ID · bdfa356b-f327-42f4-96ef-0320f7837001

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 331(a)21 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 211.22(d)21 CFR 211.165(e)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Provident Pharmaceuticals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.